financetom
Business
financetom
/
Business
/
Tesla Q1 Deliveries Drop 13% Year Over Year to 336,681 Vehicles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla Q1 Deliveries Drop 13% Year Over Year to 336,681 Vehicles
Apr 2, 2025 6:43 AM

09:16 AM EDT, 04/02/2025 (MT Newswires) -- Tesla (TSLA) delivered 336,681 vehicles in Q1, a 32.1% sequential drop and a 13% drop from the year-ago period.

The electric-vehicle maker produced 362,615 vehicles in Q1, down from 459,445 in the previous quarter and 433,371 in the year-ago quarter.

Shares were 4.3% lower in recent premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UK's antitrust regulator to probe Amazon's AI partnership with Anthropic
UK's antitrust regulator to probe Amazon's AI partnership with Anthropic
Aug 8, 2024
Aug 8 (Reuters) - Britain's competition watchdog said on Thursday it has initiated a probe into Amazon's ( AMZN ) AI partnership with Anthropic, days after it launched a similar enquiry into Alphabet's partnership with the startup. ...
Primo Water Reports Higher Q2 Adjusted Profit as Revenue Rises
Primo Water Reports Higher Q2 Adjusted Profit as Revenue Rises
Aug 8, 2024
07:09 AM EDT, 08/08/2024 (MT Newswires) -- Primo Water ( PRMW ) on Thursday reported higher adjusted profit and revenue for its second quarter. The company, which last month said it is merging with BlueTriton Brands, said adjusted net income rose to US$42 million, or US$0.26 per share, from US$31 million, or US$0.20 per share, last year. Revenue increased 7.6%...
US FDA approves Citius' blood cancer therapy
US FDA approves Citius' blood cancer therapy
Aug 8, 2024
Aug 6 (Reuters) - The U.S. Food and Drug Administration has approved Citius Pharmaceuticals' ( CTXR ) blood cancer therapy, Lymphir, for relapsed patients who have received at least one prior treatment, the company said on Thursday. The approval comes after the health regulator initially declined to approve the therapy last year, seeking additional product testing data. Lymphir, Citius' first...
Warner Bros Discovery slides as $9 billion write-down highlights TV woes
Warner Bros Discovery slides as $9 billion write-down highlights TV woes
Aug 8, 2024
(Reuters) - Shares of Warner Bros Discovery ( WBD ) plunged 12% in premarket trading on Thursday after a $9.1 billion write-down of the media giant's TV assets sparked fresh concerns about its traditional broadcasting business. The company reported a $10 billion net loss for the second quarter due to the write-down and missed Wall Street estimates for quarterly results,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved